Cyclo(Phe-Gly) TN6682
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Cyclo(Phe-Gly) shows weak antagonistic activity against VEGFR2 -CD, it also shows strong inhibitory activity against human cancer cells(KB,KBv200) with LD50 at 6.5 and 11.2 umol/L,respectively.
CAS nr:
5037-75-2
Purity:
98%
Molecular Weight:
SMILES:
Formula:
C11H12N2O2
Pathway:
Target:
